Valhi, Inc.
NYSE:VHIChemicals
-$0.44 today
- Market cap
- $452.57M
- Beta
- 0.96
- P/E (TTM)
- -5.4
- EPS (TTM)
- -$2.54
- Dividend yield
- 2.34%
Volume 0.02M
Average 0.01M
VHI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Valhi, Inc.NYSE: VHI
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 16M | -5.9% |
| FY2021 | 2021-12-31 | 17M | — |
Research & Development vs competitors
How VHI compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -100.0% is the 3rd highest of 4, against a peer median of -19.3%.
- Research & development amounts to 0.0% of revenue for VHI, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ADURAduro Clean Technologies Inc. | LTM Feb 2026 | CA$7.36M CAD | +38.8% | +73.9% | 3044.1% |
| FY2025 | $127.14K USD | -19.3% | — | 12.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | +7.7% | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding VHI) | — | -19.3% | +40.8% | 0.0% | |
Competitors are the stored peer set for VHI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.3B | 2.22B | 1.92B | 2.1B | 2.08B |
| Cost of Revenue | 1.72B | 1.73B | 1.68B | 1.68B | 1.78B |
| Gross Profit | 580.2M | 490.4M | 245.2M | 424.5M | 295.4M |
| Gross Margin | 25.3% | 22.1% | 12.8% | 20.2% | 14.2% |
| Research & Development | 17M | 16M | 0 | 0 | 0 |
| Selling, General & Admin | 328.9M | 317.9M | 289.2M | 258.8M | 312.3M |
| Operating Expenses | 311.9M | 304M | 289.2M | 258.8M | 312.3M |
| Depreciation & Amortization | 59.3M | 58.5M | 54.1M | 66.7M | 66.4M |
| EBITDA | 349.6M | 256.3M | 62.9M | 360.8M | 80.5M |
| EBITDA Margin | 15.2% | 11.5% | 3.3% | 17.1% | 3.9% |
| Operating Income | 268.3M | 186.4M | (44M) | 165.7M | (16.9M) |
| Operating Margin | 11.7% | 8.4% | -2.3% | 7.9% | -0.8% |
| Interest Income | 4M | 10.9M | 21M | 21.8M | 16.5M |
| Interest Expense | 32.5M | 27.9M | 28.3M | 49.9M | 57.1M |
| Other Income / Expenses | (10.5M) | (16.5M) | 24.5M | 78.5M | (26.1M) |
| Income Before Tax | 257.8M | 169.9M | (19.5M) | 244.2M | (43M) |
| Pre-Tax Margin | 11.2% | 7.6% | -1.0% | 11.6% | -2.1% |
| Income Tax Expense | 60.1M | 36.8M | (24.6M) | 82.9M | 11.9M |
| Net Income | 127.2M | 87.2M | (9.9M) | 108M | (57.6M) |
| Net Margin | 5.5% | 3.9% | -0.5% | 5.1% | -2.8% |
| EPS (Basic) | 4.46 | 3.16 | (0.42) | 3.79 | (2.02) |
| EPS (Diluted) | 4.46 | 3.16 | (0.42) | 3.79 | (2.02) |
| Weighted Avg Shares | 28.5M | 28.5M | 28.5M | 28.5M | 28.5M |
| Weighted Avg Shares (Diluted) | 28.5M | 28.5M | 28.5M | 28.5M | 28.5M |
Valhi, Inc.
NYSE:VHI
Intrinsic Alpha fair value
Locked
Current Price
$15.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.